公司資料
Alphatec Holdings, Inc. 股價、新聞與催化劑
- 股票代碼:
- ATEC
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
9.90 USD (-4.07%)
收盤價
最後更新: 2026年10月1日
1.15B USD
市值
股價為何變動
截至 2026年10月1日，ATEC 下跌 4.07%，收於 $9.90。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Spine-Focused Medical Technology Company
Alphatec Holdings, operating as ATEC, develops technologies intended to improve the planning and execution of spine surgery. Its product ecosystem combines implants, biologics, imaging, surgical navigation, neuromonitoring, and procedural techniques.
Procedural Innovation
ATEC develops procedure-specific systems for lateral, posterior, deformity, and other spine approaches. Techniques such as prone transpsoas surgery are supported by integrated instruments, implants, imaging, and intraoperative information intended to make complex procedures more reproducible.
InformatiX Platform
The InformatiX platform brings together EOS imaging, surgical planning, navigation, robotics, and data analytics. It is designed to support decisions before and during surgery and to connect the company's hardware with imaging and clinical information.
SafeOp Neuromonitoring
SafeOp provides automated nerve monitoring and surgical information during spine procedures. Integration with ATEC's procedural systems is intended to help surgeons understand patient anatomy and neural risk while operating.
Implant and Biologics Portfolio
ATEC sells spinal implants, fixation systems, interbody devices, and biologic products used in fusion procedures. The company develops these products as part of complete procedural solutions rather than as stand-alone implants, creating cross-selling opportunities within surgeon accounts.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。